** Shares of New Zealand-based Aroa Biosurgery Ltd ARX.AX
lose as much as 4.2% to A$1.135, their biggest one-day loss
since May 17
** The soft tissue regeneration firm announces placement of
A$47 mln ($34.6 mln) and launches A$5 mln share purchase plan
(SPP) to invest in its U.S. commercial operations urn:newsml:reuters.com:*:nASXb4Y2X7
** Co to issue around 40.3 mln new shares under the
placement, which represents about 20% of its free float
** New shares are priced at A$1.165 apiece, a discount of
1.7% to stock's last close on July 26, after which co went on a
trading halt
** SPP under similar terms as the share placement
** ARX shares at their lowest level since July 2, with
trading volumes at 675,769 shares, double the 30-day avg of
305,354
** Stock up 3% this year, as of last close
($1 = 1.3583 Australian dollars)
(Reporting by Yamini C S)
((Yamini.CS@thomsonreuters.com;))